T2 Biosystems Presents New Data At The Thrombosis And Hemostasis Summit Of North America Demonstrating Ability Of T2MR Platform Technology To Measure Platelet Activity And Additional Hemostasis Parameters
4/10/2014 7:31:28 AM
T2 Biosystems, a company developing direct detection products designed to enable superior diagnostics, today announced the presentation of data highlighting the role of its T2MR platform technology in measuring platelet function, an important parameter in assessing hemostasis and thrombosis. The company will also present data on the use of T2MR to deliver multiplex hemostasis results that include clotting time and fibrinogen generated by the company’s investigational T2Stat instrument and T2HemoStat panel, which run on the T2MR platform.
Help employers find you! Check out all the jobs and post your resume.
comments powered by